若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

EasySep™小鼠ILC2富集试剂盒

免疫磁珠负选细胞分选试剂盒

产品号 #(选择产品)

产品号 #19842_C

免疫磁珠负选细胞分选试剂盒

产品优势

  • 快速、易于操作,且无需分离柱
  • 分选得到的细胞未被标记
  • 加快ILC2s流式分选

产品组分包括

  • EasySep™小鼠ILC2富集试剂盒(产品号#19842)
    • EasySep™小鼠富集抗体混合物,5 mL
    • EasySep™ Streptavidin RapidSpheres™ 50001磁珠,0 mL
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

总览

EasySep™小鼠ILC2富集试剂盒通过负选法,从肺组织或其他组织的单细胞悬液中富集ILC2(2型先天性淋巴细胞)。利用针对非ILC细胞的生物素化抗体和链霉亲和素包被的磁珠(RapidSpheres™),来去除不需要的细胞。通过EasySep™磁极分离被标记的细胞,无需使用分离柱。

磁体兼容性
EasySep™ Magnet (Catalog #18000)
 
亚型
细胞分选试剂盒
 
细胞类型
先天性淋巴细胞
 
种属
小鼠
 
样本来源
其它细胞系
 
筛选方法
Negative
 
应用
细胞分选
 
品牌
EasySep
 
研究领域
免疫
 

实验数据

Starting with a naïve mouse lung single-cell suspension, the ILC2 content (CD45+Lin-CD278+CD90.2+ST2+) of the final enriched fraction typically ranges from 2.2 - 7.1%. In the above example, the percentage of ILC2s in the start and final enriched fractions are 0.8% and 6.5% (or 0.9% and 22.3% of CD45+ cells), respectively. NOTE: The ILC2 content of the start fraction typically ranges from 0.1 - 1%.

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
19842
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
19842
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
19842
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
19842
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

文献 (2)

Isolation and adoptive transfer of innate lymphoid cells 2 to a recipient mouse model of PDAC. A. Alam et al. STAR protocols 2022 sep

Abstract

Innate lymphoid cells 2 (ILC2) play a significant role in the tumorigenesis of pancreatic ductal adenocarcinoma (PDAC). An important aspect of ILC2-mediated tumorigenesis is the expansion of the resident ILC2 and simultaneous recruitment of the peripheral ILC2. Here, we describe a protocol for isolation, enrichment, and DiD labeling of ILC2 for in vivo tracking of ILC2s in the mouse. Further, we describe steps for the adoptive transfer of ILC2 to a recipient mouse model of PDAC. For complete details on the use and execution of this protocol, please refer to Alam et al. (2022).
IL-33 induces NF-$\kappa$B activation in ILC2 that can be suppressed by in vivo and ex vivo 17$\beta$-estradiol. S. Trivedi et al. Frontiers in allergy 2022

Abstract

Asthmatic women tend to develop severe airway disease in their reproductive years, and 30%-40% of asthmatic women have peri-menstrual worsening of asthma symptoms. This indicates that fluctuations in ovarian hormones are involved in advancement of asthmatic disease and exacerbation of symptoms. Group 2 innate lymphoid cells, or ILC2, are readily detected in allergic conditions, such as rhinosinusitis, in individuals that develop nasal polyps do to allergen exposures, and in allergic asthma. ILC2 are airway localized immune cells activated by IL-33, an innate cytokine that perpetuates allergic inflammation by driving the production of IL-5 and IL-13. We have previously shown that ILC2 are highly activated in na{\{i}}ve and ovalbumin (OVA) challenged female BALB/c mice in comparison to male mice following stimulation with IL-33. Here we investigated the effect of steady-state ovarian hormones on ILC2 and the NF-$\kappa$B signaling pathway following OVA sensitization and challenge. We found that estrogen-treated ovariectomized mice (OVX-E2) that had been challenged with OVA had reduced IL-5 and IL-13 production by lung ILC2 as compared to lung ILC2 isolated from intact male and female sham-operated controls that had been treated with OVA. ILC2 were isolated from untreated animals and co-cultured ex vivo with and without estrogen plus IL-33. Those estrogen-treated ILC2 similarly produced less IL-5 and IL-13 in comparison to untreated and had reduced NF-$\kappa$B activation. Single-cell RNA sequencing showed that 120 genes were differentially expressed in male and female ILC2 and Nfkb1 was found among top-ranked regulatory interactions. Together these results provide new insight into the suppressive effect of estrogen on ILC2 which may be protective in female asthmatics. Understanding further how estrogen modulates ILC2 may provide therapeutic targets for the treatment of allergic diseases."

更多信息

更多信息
种属 Mouse
Magnet Compatibility EasySep™ Magnet (Catalog #18000)
样本来源 Other
Selection Method Negative
标记抗体
质量保证:

产品仅供研究使用,不用于针对人或动物的诊断或治疗。 欲获悉更多关于STEMCELL的质控信息,请访问 STEMCELL.CN/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.